Are there different phenotypes of childhood asthma?

Clinical Pulmonary Medicine

Volumn 11, Issue 5, 2004, Pages 287-297

  Payne, Donald ^a   Saglani, Sejal ^a   Bush, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Airway inflammation; Asthma; Bronchial biopsy; Bronchial hyperreactivity; Bronchiolitis; Bronchoscopy; Cyclosporin; Macrolide; Persistent airflow limitation; Steroid; Subcutaneous terbutaline

Indexed keywords

ADENOSINE; ALLERGEN; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; CORTICOSTEROID; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; HYDROCORTISONE; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LUNG SURFACTANT; MACROLIDE; METHACHOLINE; NITRIC OXIDE; PREDNISOLONE; SODIUM METABISULFITE; STEROID RECEPTOR; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR;

AIRFLOW; AIRWAY OBSTRUCTION; ASTHMA; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CHILDHOOD DISEASE; CHRONIC LUNG DISEASE; COUGHING; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; INFLAMMATION; LUNG MECHANICS; NEWBORN; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHENOTYPE; PRACTICE GUIDELINE; PREMATURITY; PRESCHOOL CHILD; PRICK TEST; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SCHOOL CHILD; SKIN TEST; SPIROMETRY; STEROID THERAPY; SYMPTOMATOLOGY; WHEEZING;

EID: 4644349564     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000139466.82075.69     Document Type: Review

References (91)

1. Warner JO, Gotz M, Landau L, et al. Management of asthma: a consensus statement. Arch Dis Child. 1989;64:1065-1079.
2. Asher R. Making sense. In: Talking Sense. Bath: Pitman Medical; 1972.
3. Siersted HC, Mostgaard G, Hyldebrandt N, et al. Interrelationships between diagnosed asthma, asthma-like symptoms, and abnormal airway behaviour in adolescence: the Odense Schoolchild Study. Thorax. 1996;51:503-509.
4. rd ed. Saunders; 2003:1396-1420.
5. Silverman M, Wilson NM. Wheezing phenotypes in childhood. Thorax. 1997;52:936-937.
6. Payne DN, Balfour-Lynn I. Children with difficult asthma: a practical approach. J Asthma. 2001;38:189-203.
7. McKenzie SM, Bush A. Difficult asthma in children. Arch Dis Child. 2003;88:168-169.
8. Gemou-Engesaeth V, Kay AB, Bush A, et al. Activated peripheral blood CD4 and CDS T-lymphocytes in child asthma: correlation with eosinophilia and disease severity. Pediatr Allergy Immunol. 1994;5:170-177.
9. Gemou-Engesaeth V, Bush A, Kay AB, et al. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and "Th2-type" cytokine mRNA expression. Pediatrics. 1997;99:695-703.
10. Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643-648.
11. Leckie MJ, Ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000;356:2144-2148.
12. Bryan SA, O'Connor BJ, Matti S, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet. 2000;356:2149-2153.
13. Payne DNR, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001;164:1376-1381.
14. Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998;157:4-9.
15. Joos GF, O'Connor B, Anderson SD, et al. Indirect airway challenges. Eur Respir J. 2003;21:1050-1068.
16. Hofstra WB, Neijens HJ, Duiverman EJ, et al. Dose-response over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol. 2000;29:415-423.
17. Wilson NM, James A, Uasuf C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol. 2001;12:125-132.
18. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: the AMPUL study group. Am J Respir Crit Care Med. 1999;159:1043-1051.
19. Lodrup-Carlsen KC, Jaakkola JJ, Nafstad P, et al. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J. 1997;10:1774-1779.
20. Stick SM, Burton PR, Gurrin L, et al. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet. 1996;348:1060-1064.
21. Young S, LeSouef PN, Geelhoed GC, et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med. 1991;324:1166-1173.
22. Payne DN, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 2003;167:78-82.
23. Frey U, Makkonen K, Wellman T, et al. Alterations in airway wall properties in infants with a history of wheezing disorders. Am J Respir Crit Care Med. 2000;161:1825-1829.
24. Elliot J, Carroll N, Bosco M, et al. Increased airway responsiveness and decreased alveolar attachment points following in utero smoke exposure in the guinea pig. Am J Respir Crit Care Med. 2001;163:140-144.
25. Iles R, Edmunds T. Assessment of pulmonary function in resolving chronic lung disease of prematurity. Arch Dis Child. 1997;76:F113-117.
26. Hofhuis W, Huysman MW, van der Wiel EC, et al. Worsening of VmaxFRC in infants with chronic lung disease in the first year of life: a more favourable outcome after high-frequency oscillation ventilation. Am J Respir Crit Care Med. 2002;166:1539-1543.
27. Chan KN, Wong YC, Silverman M. Relationship between infant lung mechanics and childhood lung function in children of very low birth weight. Pediatr Pulmonol 1990;8:74-81.
28. Lebourges F, Moriette G, Boule M, et al. Pulmonary function in infancy and in childhood following mechanical ventilation in the neonatal period. Pediatr Pulmonol. 1990;9:34-40.
29. Chan KN, Noble-Jamieson CM, Elliman A, et al. Lung function in children of low birth weight. Arch Dis Child. 1989;64:1284-1293.
30. Parat S, Moriette G, Delaperche M-F, et al. Long-term pulmonary function outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol 1995;20:289-296.
31. Hakulinen AL, Jarvenpaa A-L, Turpeinen M, et al. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 1996;21:353-360.
32. Pelkonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med. 1997;156:1178-1184.
33. Cook AJ, Yuksel B, Sampson AP, et al. Cysteinyl leukotrienes involvement in chronic lung disease in premature infants. Eur Respir J. 1996;9:1907-1912.
34. Prendiville A, Rose A, Maxwell DL, et al. Hypoxaemia in wheezy infants after bronchodilator treatment. Arch Dis Child. 1987;62:997-1000.
35. Sigures N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95:500-505.
36. Henderson FW, Stewart PW, Burchinal MR, et al. Respiratory allergy and the relationship between early childhood lower respiratory illness and subsequent lung function. Am Rev Respir Dis. 1992;145:283-290.
37. Turner SW, Young S, Landau LI, et al. Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child. 2002;87:417-420.
38. Stott EJ, Taylor G, Ball LA, et al. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol. 1987;61:3855-3861.
39. Alwan WH, Kozlowska W, Openshaw PJM. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994;179:81-87.
40. Graham BS. Pathogenesis of respiratory syncytial virus augmented pathology. Am J Respir Crit Care Med. 1995;152:S63-S66.
41. Dakhama A, Bramley AM, Chan NG, et al. Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs. Eur Respir J. 1999;13:976-982.
42. O'Donnell DR, Openshaw PJ. Anaphylactic sensitization to aeroallergen during respiratory virus infection. Clin Exp Allergy. 1998;28:1501-1508.
43. Jackson M, Scott R. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins. J Med Virol. 1996;49:161-169.
44. Colasurdo GN, Hemming VG, Prince GA, et al. Human respiratory syncytial virus affects nonadrenergic noncholinergic inhibition in cotton rat airways. Am J Physiol. 1995;268:L1006-L1011.
45. Neilson K, Yunis E. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol. 1990;10:491-502.
46. Everard ML, Swarbrick A, Wrightman M, et al. Analysis of cells obtained by bronchial lavage in infants with respiratory syncytial virus infection. Arch Dis Child. 1994;71:428-432.
47. Counil FP, Lebel B, Segondy M, et al. Cells and mediators from pharyngeal secretions in infants with acute wheezing episodes. Eur Respir J. 1997;10:2591-2595.
48. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr. 1998;132:849-853.
49. Welliver RC, Sun M, Rinaldo D, et al. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr. 1986;109:776-780.
50. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody response in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol. 1993;15:19-27.
51. Everard ML. What link between early respiratory viral infections and atopic asthma? Lancet. 1999;354:527-528.
52. Aberle JH, Aberle SW, Dworzak MN, et al. Reduced interferon-y expression in peripheral blood mononuclear cells in infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med. 1999;160:1263-1268.
53. Welliver RC. The role of RSV IgE in recurrent wheezing and asthma. In: Cloutier MM, ed. RSV and Asthma: Is There a Link? American Thoracic Society; 1998;21-27.
54. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541-545.
55. Elliot JG, Carroll NG, James AL, et al. Airway alveolar attachment points and exposure to cigarette smoke in utero. Am Rev Respir Crit Care Med. 2003;167:45-49.
56. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319:1112-1117.
57. Morgan WJ, Martinez FD. Risk factors for developing wheezing and asthma in childhood. Pediatr Clin North Am. 1992;39:1185-1203.
58. Tager IB, Hanrahan JP, Tostesan TD, et al. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis. 1993;147:811-817.
59. Young S, O'Keeffe PT, Arnot J, et al. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child. 1995;72:16-24.
60. Halonen M, Stern D, Taussig LM, et al. The predictive relationship between serum IgE levels at birth and subsequent indices of lower respiratory illnesses and eczema in infants. Am Rev Respir Dis. 1992;146:866.
61. Clarke JR, Reese A, Silverman M. Bronchial responsiveness and lung function in infants with lower respiratory tract illness over the first 6 months of life. Arch Dis Child. 1992;67:1454.
62. Stick S, Arnott J, Landau Ll, et al. Bronchial responsiveness and lung function in recurrently wheezy infants. Am Rev Respir Dis. 1991;144:1012-1015.
63. Stevenson EC, Turner G, Heaney LG, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy. 1997;27:1027-1035.
64. Oswald H, Phelan PD, Lanigan A, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol. 1997;23:14-20.
65. Poder G, Nagy A, Kelemen J, et al. Prognostic data for the second follow-up in childhood wheezy bronchitis. Acta Paediatr Hung. 1992;32:43-51.
66. Sporik R, Holgate ST, Cogswell JJ. Natural history of asthma in childhood: a birth cohort study. Arch Dis Child. 1991;66:1050.
67. Barker DJP, ed. Fetal and Neonatal Origins of Adult Disease. London: British Medical Journal; 1992.
68. Strachan DP. Do chesty children become chesty adults? Arch Dis Child. 1990;65:161-162.
69. Merkus PJFM, Borsboom GJJJM, van Pelt W, et al. Growth of airways and airspaces in teenagers is related to sex but not to symptoms. J Appl Physiol. 1993;75:2045-2053.
70. Merkus PJFM, van Pelt W, van Houwelingen JC, et al. Growth of airways and airspaces in asthma: long-term effects of inhaled corticosteroids. Am Rev Respir Dis. 1993;148:1484-1489.
71. Leech SC, Holmes BJ, Kemeny DM, et al. Non-atopic wheezy children have reduced interferon gamma. Allergy. 2000;55:74-78.
72. British Thoracic Society, Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. Thorax. 2003;58(suppl 1):i1-94.
73. Payne DNR, Wilson NM, James A, et al. Evidence for different sub-groups of difficult asthma in children. Thorax. 2001;56:345-350.
74. Redline S, Wright EC, Kattan M, et al. Short term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediatr Pulmonol. 1996;21:203-210.
75. Payne DNR, McKenzie SA, Stacey S, et al. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma. Arch Dis Child. 2001;84:423-426.
76. Lex C, Payne D, Wilson NM, et al. Is a two week trial of oral prednisolone predictive of target lung function in paediatric asthma? Am J Respir Crit Care Med. 2003;167:A270.
77. Payne DN, Hubbard M, McKenzie SA. Corticosteroid unresponsiveness in asthma: primary or acquired? Pediatr Pulmonol. 1998;25:59-61.
78. Nimmagadda SR, Szefler SJ, Spahn JD, et al. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am Rev Respir Crit Care Med. 1997;155:87-93.
79. Leung D, Hamid Q, Vottero A, et al. Association of glucocorticoid insensitivity with increase expression of glucocorticoid receptor beta. J Exp Med. 1997;185:1567-1574.
80. Coren M, Rosenthal M, Bush A. The use of cyclosporin in corticosteroid dependant asthma. Arch Dis Child. 1997;77:522-523.
81. Wenzel SE, Szefler SJ, Leung DYM, et al. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med. 1997;156:737-743.
82. Meagher LC, Cousin JM, Seckl JR, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996;156:4422-4428.
83. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol. 2001;31:464-473.
84. Yasui K, Hu B, Nakazawa T, et al. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest. 1997;100:1677-1684.
85. Equi A, Balfour-Lynn I, Bush A, et al. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet. 2002;360:978-984.
86. Payne DNR, Balfour-Lynn IM, Biggart EA, et al. Subcutaneous terbutaline in children with chronic severe asthma. Pediatr Pulmonol. 2002;33:356-361.
87. van den Toorn LM, Overbeek SE, de Jongste JC, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2002;164:2107-2113.
88. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699-1705.
89. Kifle Y, Seng V, Davenport PW. Magnitude estimation of inspiratory resistive loads in children with life-threatening asthma. Am J Respir Crit Care Med. 1997;156:1530-1535.
90. Salome CM, Reddel HK, Ware SI, et al. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med. 2002;165:15-21.
91. Veen JC, Smits HH, Ravensberg AJ, et al. Impaired perception of dyspnoea in patients with severe asthma: relation to sputum eosinophils. Am J Respir Crit Care Med. 1998;158:1134-1141.